The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

Elm net profit rises 35% to SAR 1.82B in 2024; Q4 at SAR 497M 12 M 2024 Elm 9M 2024 profit leaps 29% to SAR 1.32B; Q3 at SAR 498M 9 M 2024 Elm H1 2024 profit jumps 20% to SAR 831M; Q2 at SAR 486M 6 M ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and ...

The deal will see AstraZeneca scoop up all outstanding equity of the Belgian biotech for a total consideration of $1 billion—split between an upfront payment of $425 million and up to $575 ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

HYDERABAD: Vaccine manufacturer Bharat Biotech International Limited (BBIL) is making a foray into the cell and gene therapy (CGT) space with a vertically integrated CGT and viral production ...

New technology could enable more sustainable and cheaper production of bio-oils to replace petroleum-based products in electronic, construction and automotive applications. The technology, known as ...

Visited my sister in Lancaster, PA and shopped at the West Elm Outlet store. I purchased several items from the store including a bathroom sop dispenser. When I returned home to Indiana ...

Sonnet BioTherapeutics Holdings on Tuesday said its top company official was the person who died over the weekend in a small plane crash in Somerset County. In a statement, Sonnet identified crash ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed as the “DeepSeek moment” for China’s drug industry, as biotech ...